Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Latest test results for lafora in dachshunds
Image mini wire haired dachshund
Latest tests show 8 per cent of dachshunds were affected.
Screenings show 42 per cent are carriers

Recent screenings for lafora's disease in miniature wire-haired dachshunds has revealed that 42 per cent of those tested are carriers of the disease.

The Dachshund Breed Council has reported the findings, which are in line with earlier results. Screenings from last November show 8 per cent of participating dogs were affected with lafora, while 50 per cent were clear.

Lafora's disease is a late-onset form of epilepsy affecting miniature wire-haired dachshunds, as well as beagles and basset hounds. Symptoms include the development of head and neck jerking when the dog is stimulated. Over time, it can lead to blindness and dementia.

The test is offered by Dr Berge Minassian from the Hospital for Sick Children in Canada, and was developed in conjunction with the Wire-Haired Dachshund club.

More than 400 dogs have now been tested and received their results. Of these, 250 were tested with the full DNA affected/carrier/clear test.

The breed council has urged breeders and stud dog owners to offer their support to the testing programme, by only breeding dogs that have received a negative test result for lafora.

Owners of the 8 per cent of dogs found to be affected with lafora have been encouraged to join the active Lafora Support Group and participate in the lafora progression research project, which aims to improve understanding of the management of the disease.

Speaking at the breed council's recent Neurology seminar in Surrey, neurology expert Dr Clare Rusbridge, said 45 per cent of an affected dog's life could be spent suffering debilitating jerking, seizures, confusion, anxiety, possible hallucination, difficulty walking and blindness.

Test results have been supplied to the Kennel Club and a new DNA testing scheme for the disease has been approved.

 

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
New form for online veterinary medicines retailers

The Veterinary Medicines Directorate (VMD) has produced a new online form for retailers wishing to sell veterinary medicines on the internet.

The form replace the previous Word version and is part of the VMD's ongoing commitment to digitise its processes. Anyone retailing prescription medicines online, including POM-V, POM-VPS and NFA-VPS categories, is lawfully required to register with the VMD before trading.

The change only applies to new applicants. Retailers already listed on the VMD's Register of Online Retailers or registered under the Accredited Internet Retailer Scheme (AIRS) do not need to do anything.